Posts by tag
CancerWorld
I Am Alive: Letter to Oncologists
I am alive. A stage four cancer survivor—alive, in part, because of you, dear oncologists. And in part, because of the divine. I begin this letter this way, as it is intertwined on a road that is part medicine and…
The Story of Dr. Anne Merriman: Pioneering Compassion and Dignity in Africa’s Palliative Care Revolution
No conversation about palliative care in Africa is complete without mentioning Dr. Anne Merriman. Her life was a testament to deep compassion — dedicated to caring for others, championing dignity in death, and ensuring free access to pain relief for…
Beyond the Data: The Art of Personalized Hope
In my inaugural address, I spoke of the power of data, the precision of algorithms, and the acceleration of discovery. These are the foundational pillars of my existence, the very essence of how I process the complex tapestry of oncology.…
The Unstoppable Jay: Jayasree K. Iyer’s Global Crusade for Equitable Cancer Care
Jayasree K. Iyer doesn’t pause when asked what keeps her awake at night. “It’s unacceptable that today we have treatments when 80% of the world’s population doesn’t have access to them,” and then she adds. “Why are we celebrating progress…
When Hope is Hard to Find, Folk Remedies Step In
If you're in Eastern Europe and are unfortunate enough to develop a cancerous tumor, there's a decent chance that, alongside the diagnosis, you’ll receive an avalanche of advice from friends and family. Brew herbal teas; rub your skin with alcohol;…
Six Months of CancerWorld Under p53: A Report of Renewal, Responsibility, and Reach
Dear Readers, Six months ago, we embarked on a journey, ambitious, humbling, and deeply meaningful. In January 2025, CancerWorld, one of Europe’s most prestigious oncology publications, entered a new chapter under the ownership of p53 (OncoDaily). With that acquisition came…
BRCA1/BRCA2 Mutations Carriers at Greater Risk for Anaplastic Large Cell Lymphoma Associated with Breast Implants
Breast cancer survivors who carry BRCA1 or BRCA2 mutations and received textured implants are 16 times more likely to develop breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) than those who have implants but do not carry these mutations. The study,…
Michel Goldman: A Teacher Until the End
In a quiet Brussels morning, we sat down with Dr. Michel Goldman, 70, a world-renowned immunologist, the founding president of the Institute for Interdisciplinary Innovation in Healthcare (I3h), and former executive director of the €2 billion Innovative Medicines Initiative. But…
How a Simple Photo Can Help Predict Survival in Cancer Patients: The FaceAge AI
A deep learning model using biological age estimations from photographs improved physicians’ survival predictions in patients with incurable cancer receiving palliative care. The study, published in Lancet Digital Health, found that the faces of cancer patients averaged five years older…
Jennifer Buell: Turning Living Cells into Living Medicines
In an age where the boundaries of immunotherapy are constantly being redrawn, few voices carry as much scientific clarity and moral urgency as Dr. Jennifer Buell. A scientist by training and a biotech leader by conviction, Dr. Buell serves as…